Cargando…
Evaluation of PACE4 isoforms as biomarkers in thyroid cancer
BACKGROUND: To date, no single molecular marker has been demonstrated as clinically useful in differentiating malignant from benign thyroid nodules when a fine needle aspiration falls in the “unknown significance” categories of the Bethesda Classification. PACE4, a member of the proprotein convertas...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194618/ https://www.ncbi.nlm.nih.gov/pubmed/30340539 http://dx.doi.org/10.1186/s40463-018-0311-x |